Skip to main content
Menu
SECURITY
POLITICS
THE BIG STORY
BUSINESS
SCIENCE
CULTURE
REVIEWS
Menu
Account
Account
Newsletters
Security
Politics
The Big Story
Business
Science
Culture
Reviews
Chevron
More
Expand
The Big Interview
Magazine
Events
WIRED Insider
WIRED Consulting
Newsletters
Podcasts
Video
Merch
Search
Search
Sign In
Sign In
Fred Vogelstein
Contributor
Fred Vogelstein is a former contributing editor at WIRED.
Science
Health Officials Say 'No Thanks' to Contact-Tracing Tech
Science
A Creator of the Ebola Vaccine Has Hope for Slowing Covid-19
Science
One Man's Desperate Quest to Cure His Son's Epilepsy—With Weed
Business
Zuckerberg's View of Speech on Facebook Is Stuck in 2004
Business
Facebook Puts Its Stamp—and Name—on Instagram and WhatsApp
Business
The FTC Wants More Privacy, Less Zuckerberg, at Facebook
Business
The New Antitrust Scrutiny Should Worry Silicon Valley
Business
Facebook Will Finally Pay—Billions—for Its Privacy Missteps
Business
15 Months of Fresh Hell Inside Facebook
Business
Facebook’s Head of Product Leaves After Privacy Pivot
Business
Facebook's Sloppy Data-Sharing Deals Might Be Criminal
Business
Why Should Anyone Believe Facebook Anymore?
Business
Facebook Sketches a Future With a Diminished News Feed
Business
Inside Facebook's Plan to Safeguard the 2018 Election
Business
Facebook Just Learned the True Cost of Fixing Its Problems
Business
What Problems? Facebook Stock Has Never Been More Valuable
Science
The FDA Approved its First Cannabis Drug. What Next?
Business
Big Tech Trades Splashy Conference Demos for Introspection
Business
What Did AT&T Want From Michael Cohen?
Science
An FDA Panel Just OK’d an Epilepsy Drug Made From Marijuana
More Stories